tiprankstipranks
Trending News
More News >
Bunge Global (BG)
NYSE:BG
Advertisement

Bunge Global (BG) AI Stock Analysis

Compare
1,472 Followers

Top Page

BG

Bunge Global

(NYSE:BG)

Rating:77Outperform
Price Target:
$91.00
▲(12.17% Upside)
Bunge Global's overall stock score of 76.6 reflects a strong valuation and positive technical indicators, supported by a successful merger and solid liquidity position. However, the score is moderated by concerns over declining revenue and free cash flow, as well as challenges in specific business segments.
Positive Factors
Long-Term Strategy
Despite near-term dilution, the Viterra acquisition is viewed as a good long-term move, as it provides substantial unquantified network synergies and strong liquidity.
Regulatory Approval
Bunge's proposed merger with Viterra has received the long-awaited approval from Chinese regulators.
Negative Factors
Earnings Dilution
The Viterra acquisition has resulted in significant EPS dilution on a pro forma basis, which could impact earnings negatively in the near term.
Uncertainty in Earnings
There is increasing uncertainty on earnings near-term, including the deal dilution and lack of pro forma guidance until later this year, which could result in choppy stock performance.

Bunge Global (BG) vs. SPDR S&P 500 ETF (SPY)

Bunge Global Business Overview & Revenue Model

Company DescriptionBunge Global (BG) is a leading global agribusiness and food company that operates in the sectors of agriculture, food production, and nutrition. With a presence in over 40 countries, Bunge engages in the sourcing, processing, and distribution of grains and oilseeds, as well as the production of edible oils, flour, and animal feed. The company focuses on delivering high-quality products to customers while promoting sustainable practices throughout its supply chain.
How the Company Makes MoneyBunge Global generates revenue through multiple key streams including the sale of processed agricultural products such as vegetable oils, flour, and animal feeds. The company benefits from its extensive supply chain network, which allows it to source raw materials efficiently and manage logistics effectively. Additionally, Bunge engages in trading activities, facilitating the purchase and sale of agricultural commodities on a global scale. Strategic partnerships with farmers, suppliers, and food manufacturers enhance its market reach and stability. The company's commitment to sustainability and innovation in food production also drives demand for its products, contributing to its overall earnings.

Bunge Global Earnings Call Summary

Earnings Call Date:Jul 30, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 23, 2025
Earnings Call Sentiment Positive
The earnings call reflected a generally positive outlook due to the successful completion of the Viterra merger and better-than-expected Q2 results. However, there were notable challenges, particularly in the Refined and Specialty Oils segment and the impact of uncertain biofuel policies. Despite these challenges, the strategic moves and strong liquidity position provide a solid foundation for future growth.
Q2-2025 Updates
Positive Updates
Successful Completion of Viterra Combination
Bunge completed its combination with Viterra, creating a premier agribusiness solutions company. This merger is expected to generate synergies and operational efficiencies, enhancing Bunge's global footprint and capabilities in the agribusiness sector.
Better-than-Expected Q2 Results
The second quarter exceeded expectations, driven primarily by strong processing in South America and higher margins in Brazil and Argentina. Reported EPS for Q2 was $2.61, significantly higher than $0.48 in the previous year.
Strong Liquidity Position
At the end of the quarter, Bunge had committed credit facilities of approximately $8.7 billion, with $7.6 billion unused, providing ample liquidity. The cash balance was approximately $6.8 billion in anticipation of the Viterra merger.
Positive Outlook for Global Crushing Footprint
Bunge's balanced global crushing footprint is expected to benefit from large bean crops and supportive biofuel policies, positioning the company well for future demand in both soy and soft crush margins.
Negative Updates
Decline in Adjusted Segment EBIT
Adjusted segment EBIT was $376 million in Q2, down from $519 million in the previous year. This was partially due to lower results in Europe and North America and challenges in the merchandising segment.
Challenges in Refined and Specialty Oils
Refined and Specialty Oils were negatively impacted by uncertainty related to U.S. biofuel policy and faced a more balanced global supply and demand environment, leading to decreased results in all regions.
Uncertain Biofuel Policy Impact
Uncertainty around U.S. biofuel policy has created challenges, particularly affecting the Refined and Specialty Oils segment and contributing to a softer performance outlook.
Company Guidance
In the Bunge Global Second Quarter 2025 Earnings Release and Conference Call, several key metrics and guidance points were highlighted. Bunge reported a second quarter earnings per share (EPS) of $2.61, a significant increase from $0.48 in the same period last year. The adjusted EPS was $1.31, compared to $1.73 in the prior year. Bunge maintained its full-year adjusted EPS outlook at approximately $7.75 for the legacy stand-alone Bunge, excluding the second half earnings from the recently sold corn milling business. The company's adjusted segment earnings before interest and taxes (EBIT) were $376 million, down from $519 million last year. Bunge's adjusted return on invested capital (ROIC) was 8.4%, while its trailing 12-month discretionary cash flow was approximately $1.1 billion, reflecting a cash flow yield of 9.8%. The company generated $693 million of adjusted funds from operations year-to-date and received $776 million of cash proceeds from asset sales. The merger with Viterra is expected to bring significant synergies, logistical efficiencies, and commercial opportunities. Looking forward, Bunge anticipates providing a forecast for the combined company prior to reporting third quarter earnings.

Bunge Global Financial Statement Overview

Summary
Bunge Global's financial performance is mixed. While profitability metrics are strong with healthy margins, a decline in revenue and a significant reduction in free cash flow raise concerns about future liquidity. The balance sheet is stable but shows increased liabilities, which may pose risks if not managed effectively.
Income Statement
75
Positive
The income statement reveals a decline in total revenue from $53.1 billion to $50.9 billion in the TTM period, indicating a negative revenue growth rate. However, the company maintains a stable gross profit margin of around 6.3% and a net profit margin of 2.7%. EBIT and EBITDA margins are both healthy at 3.4% and 4.6% respectively, demonstrating operational efficiency despite the decline in revenue.
Balance Sheet
70
Positive
Bunge Global's balance sheet reflects a debt-to-equity ratio of 0.94, indicating moderate leverage. The return on equity (ROE) stands at 11.6%, which is robust and suggests effective use of equity. The equity ratio is 38.2%, providing a solid capital structure. However, total liabilities have increased slightly, indicating potential caution in financial stability.
Cash Flow
65
Positive
The cash flow statement shows a significant reduction in free cash flow from $524 million to $180 million, indicating a negative free cash flow growth rate. The operating cash flow to net income ratio is 0.74, suggesting that a substantial portion of net income is backed by cash flow, but the declining free cash flow is a concern for future liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue50.86B53.11B59.54B67.23B59.15B41.40B
Gross Profit3.19B3.39B4.84B3.68B3.36B2.79B
EBITDA2.64B2.46B4.02B2.88B3.23B2.11B
Net Income1.38B1.14B2.24B1.61B2.08B1.15B
Balance Sheet
Total Assets31.15B24.90B25.37B24.58B23.82B23.66B
Cash, Cash Equivalents and Short-Term Investments7.14B3.79B2.71B1.22B1.42B698.00M
Total Debt12.21B7.12B5.76B5.62B6.82B8.10B
Total Liabilities19.20B13.95B13.56B14.62B15.61B17.04B
Stockholders Equity10.88B9.91B10.85B9.22B7.67B6.07B
Cash Flow
Free Cash Flow180.00M524.00M2.19B-6.10B-3.29B-3.90B
Operating Cash Flow1.02B1.90B3.31B-5.55B-2.89B-3.54B
Investing Cash Flow-668.00M-1.11B-1.01B6.50B5.11B1.81B
Financing Cash Flow5.24B-90.00M-856.00M-769.00M-1.63B1.76B

Bunge Global Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price81.13
Price Trends
50DMA
79.34
Positive
100DMA
78.74
Positive
200DMA
77.41
Positive
Market Momentum
MACD
0.96
Positive
RSI
47.95
Neutral
STOCH
11.62
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BG, the sentiment is Neutral. The current price of 81.13 is below the 20-day moving average (MA) of 82.78, above the 50-day MA of 79.34, and above the 200-day MA of 77.41, indicating a neutral trend. The MACD of 0.96 indicates Positive momentum. The RSI at 47.95 is Neutral, neither overbought nor oversold. The STOCH value of 11.62 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BG.

Bunge Global Risk Analysis

Bunge Global disclosed 41 risk factors in its most recent earnings report. Bunge Global reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Bunge Global Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
84
Outperform
$5.48B4.4355.96%7.36%83.19%339.22%
77
Outperform
$29.81B27.314.93%3.28%-6.70%-54.38%
77
Outperform
$16.29B8.1313.20%3.40%-8.87%13.21%
76
Outperform
$1.71B11.577.49%3.20%1.41%
71
Outperform
$10.03B
3.09%
66
Neutral
$19.72B25.134.31%3.56%1.99%
63
Neutral
$20.50B14.76-2.72%3.09%1.90%-4.74%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BG
Bunge Global
81.13
-14.43
-15.10%
ADM
Archer Daniels Midland
62.94
5.73
10.02%
CALM
Cal-Maine Foods
113.83
50.87
80.80%
FDP
Fresh Del Monte Produce
35.71
8.16
29.62%
TSN
Tyson Foods
56.20
-7.39
-11.62%
SFD
Smithfield Foods
23.81
4.00
20.19%

Bunge Global Corporate Events

Private Placements and Financing
Bunge Global Completes $1.3 Billion Senior Notes Sale
Neutral
Aug 4, 2025

On July 31, 2025, Bunge Limited Finance Corp., a subsidiary of Bunge Global SA, completed the sale and issuance of $1.3 billion in senior notes, divided into two tranches due in 2030 and 2035. The proceeds from this offering, which was managed by several major financial institutions, are intended for general corporate purposes, including debt repayment and investments, potentially impacting Bunge’s financial flexibility and market positioning.

Private Placements and FinancingBusiness Operations and Strategy
Bunge Global Completes Exchange Offers and Solicitations
Neutral
Jul 8, 2025

On July 8, 2025, Bunge Limited Finance Corp., a subsidiary of Bunge Global SA, completed its exchange offers and consent solicitations for various notes issued by Viterra Finance B.V. This involved exchanging existing Viterra notes for new Bunge notes and cash, and amending the terms of the existing notes to eliminate certain covenants and provisions. The completion of these offers resulted in the issuance of new notes with different interest rates and maturity dates, impacting Bunge’s financial operations and obligations. The remaining Viterra notes that were not exchanged will continue under the modified terms.

M&A TransactionsBusiness Operations and Strategy
Bunge Global Finalizes Viterra Exchange Offers Results
Neutral
Jul 7, 2025

On July 7, 2025, Bunge Global SA announced the expiration and final results of its Exchange Offers and Consent Solicitations related to Viterra’s outstanding notes, following the completion of Bunge’s acquisition of Viterra on July 2, 2025. The Exchange Offers, which expired on July 3, 2025, involved exchanging Viterra’s notes for new notes issued by Bunge Limited Finance Corp. and cash, with sufficient consents received to amend existing indentures and release guarantees. The settlement is expected on July 8, 2025, marking a significant step in Bunge’s strategic integration of Viterra, potentially impacting its financial structure and market positioning.

M&A TransactionsBusiness Operations and Strategy
Bunge Global Completes Merger with Viterra Limited
Positive
Jul 2, 2025

On July 2, 2025, Bunge Global completed its merger with Viterra Limited, creating a premier global agribusiness solutions company. This strategic combination aims to enhance Bunge’s capabilities in connecting farmers to consumers, with a focus on meeting the evolving needs of customers and maximizing stakeholder value. The merger is expected to provide significant financial and operational benefits, including improved logistics, trading optionality, and a more stable cash flow profile. Additionally, the merger brings together experienced management teams to drive value creation and operational efficiency.

M&A TransactionsRegulatory Filings and Compliance
Bunge Global Amends Business Combination Agreement
Neutral
Jun 13, 2025

On June 13, 2025, Bunge, along with Glencore, CPPIB, and BCI, amended their Business Combination Agreement, setting the closing date for their transactions, including an acquisition, to July 2, 2025. The amendment also extended the outside date to July 3, 2025, and waived certain conditions for closing. Approvals were received from regulatory bodies in China and Mexico, satisfying antitrust and foreign investment laws, with the transactions expected to be completed on July 2, 2025.

Private Placements and FinancingM&A Transactions
Bunge Global Extends Exchange Offers for Viterra Acquisition
Neutral
Jun 12, 2025

On June 12, 2025, Bunge Global SA announced that its subsidiary, Bunge Limited Finance Corp., extended the expiration date for its exchange offers and consent solicitations related to Viterra Finance B.V.’s notes. This extension is part of Bunge’s pending acquisition of Viterra, with the expiration date moved to July 3, 2025, to accommodate the completion of the business combination. The extension aims to facilitate the exchange of existing notes for new Bunge notes and cash, while also amending certain indentures to eliminate covenants and modify provisions. The move is expected to impact the liquidity of Viterra’s existing notes and reduce protections for remaining holders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2025